---
title: 'The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic
  cancer: an international multicenter study'
date: '2025-01-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39814200/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250116171035&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Neoadjuvant therapy in patients with left-sided RPC was
  associated with improved OS compared to upfront surgery. The impact of neoadjuvant
  therapy increased with larger tumor size and higher serum CA19-9 at diagnosis. Randomized
  controlled trials on neoadjuvant therapy specifically in patients with left-sided
  RPC are ...'
disable_comments: true
---
CONCLUSIONS: Neoadjuvant therapy in patients with left-sided RPC was associated with improved OS compared to upfront surgery. The impact of neoadjuvant therapy increased with larger tumor size and higher serum CA19-9 at diagnosis. Randomized controlled trials on neoadjuvant therapy specifically in patients with left-sided RPC are ...